 Dr. Canhua HUANG Professor of The State Key Lab of Biotherapy, West China Hospital, Sichuan University Director of Tianfu Jincheng Laboratory [Resume] Prof. Huang received his doctor's degree from Chinese Academy of Sciences in 2000. From July 2024 to the present, he has served as the director of Tianfu Jincheng Laboratory.After accomplishing his postdoctoral research at National University of Singapore, he was hired as a Research Scientist of Oncology Research Institute, National University of Singapore in 2003. He returned to China in 2005 and was appointed as a Professor of the State Key Lab of Biotherapy, West China Hospital, Sichuan University. He was appointed as the dean of West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University from 2017 to 2021. In 2012, he won the National Science Fund for Distinguished Young Scholars of China, and took up the post of the Chief Scientist for National 973 Program entitled “Proteomics Profiling of the Redoxomes Associated with Virus-induced Carcinogenesis” from 2013 to 2017. In 2014, he was hired as the Changjiang Scholars Program Endowed Professor. In 2018, he served as the director of an Innovative Research Group of the National Nature Science Foundation of China, entitled “Redox Signaling Regulation and Carcinogenesis”. In 2020, he was a member of the 8th Discipline Evaluation Group of Academic Degrees Committee of The State Council (Basic Medicine Group). He was selected by Elsevier 2020, 2021, 2022 and 2023 China Highly Cited Scholar and won the First Prize of Natural Science Award of the Ministry of Education in 2020. He was awarded special allowance by State Council in 2018. In 2019, he was honored as the person in charge of the innovation team in key fields of the "Innovative Talent Promotion Program" of the Ministry of Science and Technology and the leading talent in scientific and technological innovation of the fourth batch of the national "Ten Thousand Talents Program" of the Organization Department of the CPC.and he serves as an executive director of the Chinese Society for Biochemistry and Molecular Biology and the chairman of the Sichuan Society for Biochemistry and Molecular Biology.In 2023, he served as a director of the Huaxia Medical Science and Technology Award Council of the China International Exchange and Promotive Association for Medical and Health Care.In 2023, he served as the Chief Scientist of National Key Research and Development Program of China "The mechanism and intervetion strategies of oxidative stress-mediated protein dynamic modification in tumor".In 2024, he served as the vice president of the Sichuan International Medical Exchange Promotion Association.He is a member of the 12th and 13th Sichuan Provincial Committee of the Chinese People's Political Consultative Conference; an expert member of the Sichuan non-party expert database for making suggestions; and an expert member of the "Concentric Think Tank" of the united front in Chengdu.He is also the deputy secretary-general of the Chengdu Overseas Returned Scholars Association and the director of the Biomedical Specialized Committee; a standing director of the Chengdu Overseas Friendship Association. Prof. Huang has published over 120 papers in international academic journals as the corresponding author, including Nat Microbiol, Nat Commun, Cell Rep, Gastroenterology, J Hepatol, Hepatology, EMBO Mol Med, Cancer Res, Drug Resist Updat, J Extracell Vesicles, Autophagy, Mol Cancer, Adv Funct Mater, Adv Sci (Weinh), Cell Death Differ, Oncogene, Mol Cell Proteomics and many others. In addition, he was invited to contribute multiple review articles on the frontiers of systems biology in international academic journals, such as Trends Biochem Sci, Signal Transduct Target Ther, Semin Cancer Biol, Drug Resist Updat, J Hematol Oncol, Mass Spectrom Rev, Antioxid Redox Signal, Med Res Rev, Biochim Biophys Acta Rev Cancer. Moreover, he holds several important editorial positions in international academic publications. He serves as the Editor-in-Chief of MedComm - Oncology, Deputy Editor-in-Chief of MedComm, Consultant Editor of Antioxidants, Executive Editor of Anal Biochem, and is a member of the editorial boards of Signal Transduct Target Ther, Proteomics and other relevant journals. . [Research interest] Redox regulation in tumorigenesis The mechanism of virus-induced tumorigenesis [Laboratory homepage website] Recently, the Innovation Class of State Key Lab of Biotherapy aims at cultivating "inter-disciplinary talent with a solid foundation in biology and chemistry, and a medical or pharmaceutical foundation, with innovative consciousness and a certain level of scientific research capabilities." The class has received strong support from the school and plans to select 80 outstanding students in the Class 2015 students of science, engineering, and medical majors of the university to carry out careful cultivation. The tutors in the innovation class are Academicians, Changjiang Scholars Program Endowed Professors, winners of the National Science Fund for Distinguished Young Scholars or Outstanding Youth Science Foundation of China, National "Thousand Talents Program" Scholars or Youth Scholars, or outstanding doctoral tutors.
Our lab attaches great importance to the education of undergraduates. Professor Huang has been awarded "Outstanding Instructor for Top Innovative Talents" by Sichuan University for five consecutive years. Our lab is based on "honesty" and the students are "United with love and make progress together". Former undergraduate students have published academic papers in international academic journals including Mol Cell Proteomics, Autophagy, Free Radical Bio Med, and Int J Cancer. The first authors of 14 papers are undergraduates. We warmly welcome undergraduates who are honest and trustworthy and interested in life sciences to study in our lab. There are no other requirements.  |
